Heat Stroke in Phenothiazine-Treated Patients: A Report of Three Fatalities
Abstract
During a heat wave in July 1969, the authors encountered three fatal cases of heat stroke. All the patients had been treated with phenothiazines, which affect temperature regulation and suppress sweating, and two with anti-Parkinsonian agents, which also suppress sweating. The authors stress the need for lower phenothiazine dosages where possible, limited use of supplemental anticholinergic agents, and awareness of the susceptibility of phenothiazine-treated patients to the hazards of extreme temperatures.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
